These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33552363)

  • 1. Effects of COVID-19 on the laboratory turn-around time of vaccine-preventable disease surveillance: the case of measles in South Sudan.
    Kunjok DM; Zingbondo IM
    Pan Afr Med J; 2020; 37():245. PubMed ID: 33552363
    [No Abstract]   [Full Text] [Related]  

  • 2. How Can We Identify the Elimination of Infectious Diseases? Experience From an Active Measles Laboratory Surveillance System in the Republic of Korea.
    Yang TU; Kang HJ; Eom HE; Park YJ; Park O; Kim SJ; Nam JG; Kim SS; Jeong EK
    Asia Pac J Public Health; 2015 Nov; 27(8 Suppl):101S-109S. PubMed ID: 26023151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles: A dangerous vaccine-preventable disease returns.
    Porter A; Goldfarb J
    Cleve Clin J Med; 2019 Jun; 86(6):393-398. PubMed ID: 31204978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the COVID-19 pandemic on measles surveillance in the World Health Organisation African Region, 2020.
    Masresha B; Luce R; Katsande R; Dosseh A; Tanifum P; Lebo E; Byabamazima C; Kfutwah A
    Pan Afr Med J; 2021; 39():192. PubMed ID: 34603573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of vaccine exemptions in the resurgence of measles.
    Nimblett-Clarke A
    JAAPA; 2021 Feb; 34(2):36-40. PubMed ID: 33470720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Better surveillance and vaccine coverage are needed to eliminate measles in India by 2020.
    Travasso C
    BMJ; 2015 Feb; 350():h900. PubMed ID: 25701024
    [No Abstract]   [Full Text] [Related]  

  • 7. The return of measles--an unnecessary sequel.
    Mandell BF
    Cleve Clin J Med; 2019 Jun; 86(6):365-366. PubMed ID: 31204975
    [No Abstract]   [Full Text] [Related]  

  • 8. Measles: Why it's still a threat.
    Campos-Outcalt D
    J Fam Pract; 2017 Jul; 66(7):446-449. PubMed ID: 28700761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress towards measles elimination -South-East Asia Region, 2003-2013.
    Wkly Epidemiol Rec; 2015 Jun; 90(24):297-305. PubMed ID: 26072524
    [No Abstract]   [Full Text] [Related]  

  • 10. Resurgence of Vaccine-Preventable Disease: Ethics in the Pediatric Emergency Department.
    Dreisinger N; Lim CA
    Pediatr Emerg Care; 2019 Sep; 35(9):651-653. PubMed ID: 31449198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. South Sudan tackles measles outbreaks.
    Bagcchi S
    Lancet Infect Dis; 2023 Apr; 23(4):409. PubMed ID: 36965494
    [No Abstract]   [Full Text] [Related]  

  • 12. [Measles surveillance in Germany. From sentinel to mandatory surveillance].
    Siedler A; Grüber A; Mankertz A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1321-8. PubMed ID: 23990096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles: South Sudan reports 12 000 cases in three months.
    Mahase E
    BMJ; 2024 Mar; 384():q777. PubMed ID: 38548295
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of accurate diagnosis in the assessment of impact of immunisation campaigns: case study of a measles immunisation programme in Madagascar.
    Garry SF
    Public Health; 2009 Jan; 123(1):72-3. PubMed ID: 19049839
    [No Abstract]   [Full Text] [Related]  

  • 15. Measles control in Australia. Report of the Measles Control in Australia Workshop, 5 November 1997.
    Forrest JM; Burgess MA; Heath TC; McIntyre PB
    Commun Dis Intell; 1998 Mar; 22(3):33-6. PubMed ID: 9557386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles Elimination Activities in the Western Pacific Region: Experience from the Republic of Korea.
    Choe YJ; Jee Y; Oh MD; Lee JK
    J Korean Med Sci; 2015 Nov; 30 Suppl 2(Suppl 2):S115-21. PubMed ID: 26617443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiologic surveillance of measles and rubella in Campinas (SP), Brazil: the reliability of the data].
    de Barros EN; Silva EM
    Rev Panam Salud Publica; 2006 Mar; 19(3):172-8. PubMed ID: 16640846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. South-East Asia Regional update on measles mortality reduction and elimination, 2003-2008.
    O'Connor PM; Liyanage JB; Mach O; Anand A; Ramamurty N; Balakrishnan MR; Singh S
    J Infect Dis; 2011 Jul; 204 Suppl 1():S396-402. PubMed ID: 21666190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global and national laboratory networks support high quality surveillance for measles and rubella.
    Xu W; Zhang Y; Wang H; Zhu Z; Mao N; Mulders MN; Rota PA
    Int Health; 2017 May; 9(3):184-189. PubMed ID: 28582561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles surveillance: guidelines for laboratory support.
    Can Commun Dis Rep; 1999 Dec; 25(24):201-16. PubMed ID: 10715907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.